Study finds no shortage of misleading HPV vaccine websites

Research published by the Journal of Adolescent Health demonstrates a reality that Big Pharmas Merck & Co. ($MRK) and GlaxoSmithKline ($GSK) have experienced for years: There's an abundance of misinformation circulating about HPV vaccines. A team led by Dr. Linda Fu at George Washington University completed 20 different searches using a variety of terms linked with HPV vaccines and came across 116 websites, 39% of which were critical. In some cases, the misleading or incomplete sites highlighted safety concerns with the vaccines and contended that the vaccines encourage sexual activity, two misperceptions that have hampered uptake and dragged on sales in the vaccine category for some time. More from FierceVaccines

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.

AbbVie and Allergan's merger may create the fourth-largest drugmaker in the world, but it could also create opportunities for other drugmakers.